We estimated the prevalence of anti-SARS-CoV-2 IgG antibodies for the S1 subunit of the spike glycoprotein and factors potentially associated with SARS-CoV-2 infection 6 months after the beginning of the first wave of COVID-19 in Belém, Pará, Brazil. The gene discussed is PSMD1; the disease is COVID-19.